Current Use of Thalamic Vim Stimulation in Treating Parkinson’s Disease
Naoki Tani(Osaka Gakuin University), Satoshi Goto(Ritsumeikan University), Ryuji Kaji(Tokushima University), Ryoma Morigaki(Tokushima University)
Cited by 6
Related Papers
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
|Nature Communications|2012|599
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells
|Developmental Cell|2020|211
Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis
|Neurobiology of Aging|2012|132